首页> Advances in cancer research> The epigenome and the many facets of cancer drug tolerance.

The epigenome and the many facets of cancer drug tolerance.

导出 LinkOut

翻译打印收藏纠错

第一作者： Paul C,Moore

第一单位： Pfizer Centers for Therapeutic Innovation, San Francisco, CA, United States.

作者： Paul C,Moore ^[1] ; Kurt W,Henderson ^[1] ; Marie,Classon ^[2]

作者单位： Pfizer Centers for Therapeutic Innovation, San Francisco, CA, United States. ^[1] Pfizer Centers for Therapeutic Innovation, San Francisco, CA, United States. Electronic address: marie.classon@pfizer.com. ^[2]

关键词 Cancer stem cells Drug-tolerant persisters Epigenetics Histone methylation Plasticity Subpopulations Tumor heterogeneity Tumor microenvironment

医学主题词人类(Humans);抗药性, 肿瘤(Drug Resistance, Neoplasm);肿瘤(Neoplasms);抗肿瘤药(Antineoplastic Agents);药物耐受性(Drug Tolerance);肿瘤微环境(Tumor Microenvironment)

DOI 10.1016/bs.acr.2022.12.002

PMID 36990531

发布时间 2023-04-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Advances in cancer research

2023年158卷

1-39页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Advances in cancer research

2023年158卷

1-39页

检索历史清除

The epigenome and the many facets of cancer drug tolerance.

Advances in cancer research

相似文献

同项目论文

Advances in cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The epigenome and the many facets of cancer drug tolerance.

Advances in cancer research

相似文献

同项目论文

Advances in cancer research

相关期刊

检索历史清除